Ovarian small cell carcinoma of hypercalcemic type - Evidence of germline origin and SMARCA4 gene inactivation. A pilot study

Polish Journal of Pathology

Volumn 64, Issue 4, 2013, Pages 238-246

  Kupryjańczyk, Jolanta ^a   Dansonka Mieszkowska, Agnieszka ^a   Moes Sosnowska, Joanna ^a   Plisiecka Hałasa, Joanna ^a   Szafron, Łukasz ^a   Podgórska, Agnieszka ^a   Rzepecka, Iwona K ^a   Konopka, Bozena ^a   Budziłowska, Agnieszka ^a   Rembiszewska, Alina ^a   Grajkowska, Wiesława ^b   Śpiewankiewicz, Beata ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

Author keywords

Atypical teratoid rhabdoid tumor; Embryonal tumor; Immature teratoma; Ovary; Rhabdoid tumor; Small cell carcinoma of hypercalcemic type

Indexed keywords

DNA; DNA HELICASE; NUCLEAR PROTEIN; SMARCA4 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR MARKER;

ADULT; ARTICLE; CHEMISTRY; DIFFERENTIAL DIAGNOSIS; DNA SEQUENCE; FEMALE; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; GERMLINE MUTATION; HUMAN; METABOLISM; OVARY TUMOR; PATHOLOGY; PILOT STUDY; PREGNANCY; PROSPECTIVE STUDY; RHABDOID TUMOR; SMALL CELL CARCINOMA; TERATOMA;

ADULT; CARCINOMA, SMALL CELL; DIAGNOSIS, DIFFERENTIAL; DNA HELICASES; DNA, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GERM-LINE MUTATION; HUMANS; NUCLEAR PROTEINS; OVARIAN NEOPLASMS; PILOT PROJECTS; PREGNANCY; PROSPECTIVE STUDIES; RHABDOID TUMOR; SEQUENCE ANALYSIS, DNA; TERATOMA; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84891427913     PISSN: 12339687     EISSN: None     Source Type: Journal    
DOI: 10.5114/PJP.2013.39331     Document Type: Article

References (20)

1. Young RH, Oliva E, Scully RE. Small cell carcinoma of the ovary, hypercalcemic type. A clinicopathological analysis of 150 cases. Am J Surg Pathol 1994; 18: 1102-1116.
2. Harrison ML, Hoskins P, du Bois A, et al. Small cell of the ovary, hypercalcemic type - analysis of combined experience and recommendation for management. A GCIG study. Gynecol Oncol 2006; 100: 233-238.
3. Dickersin GR, Kline IW, Scully RE. Small cell carcinoma of the ovary with hypercalcemia: a report of eleven cases. Cancer 1982; 49: 188-197.
4. Ulbright TM, Roth LM, Stehman FB, et al. Poorly differentiated (small cell) carcinoma of the ovary in young women: evidence supporting a germcell origin.HumPathol 1987; 18: 175-184.
5. Aguirre P, Thor AD, Scully RE. Ovarian small cell carcinoma. Histogenetic considerations based on immunohistochemical and other findings. Am J Clin Pathol 1989; 92: 140-149.
6. Stephens B, Anthony SP, Han H, et al. Molecular characterization of a patient's small cell carcinoma of the ovary of the hypercalcemic type. J Cancer 2012; 3: 58-66.
7. Schneppenheim R, Frühwald MC, Gesk S, et al. Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome. Am J Hum Genet 2010; 86: 279-284.
8. Dansonka-Mieszkowska A, Kluska A, Moes J, et al. A novel germline PALB2 deletion in Polish breast and ovarian cancer patients. BMC Med Genet 2010; 11: 20.
9. Medina PP, Carretero J, Fraga MF, et al. Genetic and epigenetic screening for gene alterations of the chromatin-remodeling factor, SMARCA4/BRGI, in lung tumors. Genes Chromosomes Cancer 2004; 41: 170-177.
10. Walt H, Hornung R, Fink D, et al. Hypercalcemic-type of small cell carcinoma of the ovary: characterization of a new tumor line. Anticancer Res 2001; 21: 3253-3259.
11. Wallentine JC. Rhabdoid tumor. In: Diagnostic pathology. Pediatric neoplasms. Putnam AR, et al. (eds.). Amirsys, Salt Lake City 2012; 14: 8-11.
12. Burger PC. Atypical teratoid/rhabdoid tumor. In: Diagnostic pathology. Neuropathology. Burger PC, et al. (eds.). Amirsys, Salt Lake City 2012; I-1, 248-255.
13. Haas JE, Palmer NF, Weinberg AG, Beckwith JB. Ultrastructure of malignant rhabdoid tumor of the kidney. A distinctive renal tumor of children. Hum Pathol 1981; 12: 646-657.
14. Biggs PJ, Garen PD, Powers JM, Garvin AJ. Malignant rhabdoid tumor of the central nervous system. Hum Pathol 1987; 18: 332-337.
15. Gamwell LF, Gambaro K, Merziotis M, et al. Small cell ovarian carcinoma: genomic stability and responsiveness to therapeutics. Orphanet J Rare Dis 2013; 8: 33.
16. Scully RE. Atlas of tumor pathology. Rosai J (ed.). Armed Forces Institute of Pathology,Washington DS 1998; 316.
17. Ohi S, Niimi S, Okada N, et al. Establishment and characterization of a human ovarian small cell carcinoma, hypercalcemic type, cell line (OS-1) secreting PTH, PthrP and ACTH - special reference to the susceptibility of anti-cancer drugs. Hum Cell 2004; 17: 203-209.
18. Chen L, Dinh TA, Haque A. Small cell carcinoma of the ovary with hypercalcemia and ectopic parathyroid hormone production. Arch Pathol Lab Med 2005; 129: 531-533.
19. Oike T, Ogiwara H, Nakano T, et al. Inactivating mutations in SWI/SNF chromatin remodeling genes in human cancer. Jpn J Clin Oncol 2013; 43: 849-855.
20. Hasselblatt M, Gesk S, Oyen F, et al. Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expression. Am J Surg Pathol 2011; 35: 933-935.